144 related articles for article (PubMed ID: 8500098)
1. Chromosome 22 heterozygosity is retained in most hyperdiploid and pseudodiploid meningiomas.
Bello MJ; de Campos JM; Vaquero J; Kusak ME; Sarasa JL; Rey JA; Pestaña A
Cancer Genet Cytogenet; 1993 Apr; 66(2):117-9. PubMed ID: 8500098
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal involvement secondary to -22 in human meningiomas.
Rey JA; Bello MJ; de Campos JM; Kusak E; Moreno S
Cancer Genet Cytogenet; 1988 Jul; 33(2):275-90. PubMed ID: 3383169
[TBL] [Abstract][Full Text] [Related]
3. Loss of genes on the long arm of chromosome 22 in human meningiomas.
Okazaki M; Nishisho I; Tateishi H; Motomura K; Yamamoto M; Miki T; Hayakawa T; Takai S; Honjo T; Mori T
Mol Biol Med; 1988 Feb; 5(1):15-22. PubMed ID: 2897611
[TBL] [Abstract][Full Text] [Related]
4. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
5. Lack of isodisomy for chromosome 22 in disomic meningiomas.
Blin N; Schneider G; Janka M; Subke F; Zang KD; Meese E
Cytogenet Cell Genet; 1995; 71(2):139-41. PubMed ID: 7656583
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity for chromosome 22 DNA sequences in human meningioma.
Cogen PH; Daneshvar L; Bowcock AM; Metzger AK; Cavalli-Sforza LL
Cancer Genet Cytogenet; 1991 Jun; 53(2):271-7. PubMed ID: 1676608
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
[TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of human meningiomas and schwannomas.
Jacoby LB; Pulaski K; Rouleau GA; Martuza RL
Cancer Res; 1990 Nov; 50(21):6783-6. PubMed ID: 2208143
[TBL] [Abstract][Full Text] [Related]
9. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
10. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.
Dumanski JP; Carlbom E; Collins VP; Nordenskjöld M
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9275-9. PubMed ID: 2892198
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
Dumanski JP; Rouleau GA; Nordenskjöld M; Collins VP
Cancer Res; 1990 Sep; 50(18):5863-7. PubMed ID: 2393856
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and the origin of meningioma.
Meese E; Blin N; Zang KD
Hum Genet; 1987 Dec; 77(4):349-51. PubMed ID: 2891603
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
16. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss at 1p is associated with tumor progression of meningiomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.
Lekanne Deprez RH; Riegman PH; van Drunen E; Warringa UL; Groen NA; Stefanko SZ; Koper JW; Avezaat CJ; Mulder PG; Zwarthoff EC
J Neuropathol Exp Neurol; 1995 Mar; 54(2):224-35. PubMed ID: 7876890
[TBL] [Abstract][Full Text] [Related]
20. Meningiomas: karyotypes and histological patterns.
Lopez-Gines C; Piquer J; Cerda-Nicolas M; Barcia-Salorio J; Barcia-Marino C
Clin Neuropathol; 1989; 8(3):130-3. PubMed ID: 2743649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
